Mark Orloff
| Title | Professor |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Surgery |
|---|
| Address | University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box SURG
Rochester NY 14642
|
|---|
|
|
|
| Title | Director |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Surgery |
|---|
| Division | Surgery - Transplant |
|---|
|
|---|
|
| 1984 |
|
| NATO Scholarship | | 1991 |
|
| Buswell Award
University of Rochester | | 1997 |
|
| James IV Traveling Scholar |
-
Connolly GC, Safadjou S, Kashyap R, Chen R, Orloff MS, Hezel AF. Diabetes mellitus impacts risk of macrovascular invasion in patients undergoing transplantation for hepatocellular carcinoma. BMC Gastroenterol. 2013; 13:9.
-
Raghuram A, Restrepo A, Safadjou S, Cooley J, Orloff M, Hardy D, Butler S, Koval CE. Invasive fungal infections following liver transplantation: Incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007). Liver Transpl. 2012 Sep; 18(9):1100-9.
-
Hamalainen-Laanaya HK, Orloff MS. Analysis of cell viability using time-dependent increase in fluorescence intensity. Anal Biochem. 2012 Oct 1; 429(1):32-8.
-
Tu Z, Hamalainen-Laanaya HK, Nishitani C, Kuroki Y, Crispe IN, Orloff MS. HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation. Int Immunol. 2012 Feb; 24(2):97-106.
-
Barry CT, D'Souza M, McCall M, Safadjou S, Ryan C, Kashyap R, Marroquin C, Orloff M, Almudevar A, Godfrey TE. Micro RNA expression profiles as adjunctive data to assess the risk of hepatocellular carcinoma recurrence after liver transplantation. Am J Transplant. 2012 Feb; 12(2):428-37.
-
Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up. Transplantation. 2011 Aug 27; 92(4):453-60.
-
Tu Z, Hamalainen-Laanaya HK, Crispe IN, Orloff MS. Synergy between TLR3 and IL-18 promotes IFN-? dependent TRAIL expression in human liver NK cells. Cell Immunol. 2011; 271(2):286-91.
-
Zand MS, Orloff MS, Abt P, Patel S, Tsoulfas G, Kashyap R, Jain A, Safadjou S, Bozorgzadeh A. High mortality in orthotopic liver transplant recipients who require hemodialysis. Clin Transplant. 2011 Mar-Apr; 25(2):213-21.
-
Nickels MW, Cullen JP, Demme RA, Vetter M, Boulay R, Betts R, McKee M, Orloff M, Bozorgzadeh A. A psychosocial evaluation process for living liver donors: the University of Rochester model. Int J Psychiatry Med. 2011; 41(4):295-308.
-
Kashyap R, Safadjou S, Chen R, Mantry P, Sharma R, Patil V, Maloo M, Ryan C, Marroquin C, Barry C, Ramaraju G, Maliakkal B, Orloff M. Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases--an analysis of the UNOS database. J Gastrointest Surg. 2010 Sep; 14(9):1362-9.
-
Jain AB, Patil V, Sheikh B, Apostolakos M, Ryan C, Kashyap R, Orloff M. Effect of liver transplant on pulmonary functions in adult patients with alpha 1 antitrypsin deficiency: 7 cases. Exp Clin Transplant. 2010 Mar; 8(1):4-8.
-
Delair S, Feeley TH, Kim H, Del Rio Martin J, Kim-Schluger L, Lapointe Rudow D, Orloff M, Sheiner PA, Teperman L. A peer-based intervention to educate liver transplant candidates about living donor liver transplantation. Liver Transpl. 2010 Jan; 16(1):42-8.
-
Sharma R, Kashyap R, Jain A, Safadjou S, Graham M, Dwivedi AK, Orloff M. Surgical complications following liver transplantation in patients with portal vein thrombosis--a single-center perspective. J Gastrointest Surg. 2010 Mar; 14(3):520-7.
-
Jain A, Nemitz P, Sharma R, Sheikh B, Safadjou S, Vetter M, Brayan L, Batzold P, Kashyap R, Orloff M. Incidence of abdominal wall numbness post-liver transplantation and its complications. Liver Transpl. 2009 Nov; 15(11):1488-92.
-
Kashyap R, Ryan C, Sharma R, Maloo MK, Safadjou S, Graham M, Tretheway D, Jain A, Orloff M. Liver grafts from donors with central nervous system tumors: a single-center perspective. Liver Transpl. 2009 Oct; 15(10):1204-8.
-
Tu Z, Pierce RH, Kurtis J, Kuroki Y, Crispe IN, Orloff MS. Hepatitis C virus core protein subverts the antiviral activities of human Kupffer cells. Gastroenterology. 2010 Jan; 138(1):305-14.
-
Jain A, Fiaz O, Sheikh B, Sharma R, Safadjou S, Kashyap R, Bryan L, Batzold P, Orloff M. Recurrent nonhepatic and de novo malignancies after liver transplantation. Transplantation. 2009 Sep 15; 88(5):706-10.
-
Kashyap R, Mantry P, Sharma R, Maloo MK, Safadjou S, Qi Y, Jain A, Maliakkal B, Ryan C, Orloff M. Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis. J Gastrointest Surg. 2009 Aug; 13(8):1480-6.
-
Choi DX, Jain AB, Orloff MS. Utility of transjugular intrahepatic portosystemic shunts in liver-transplant recipients. J Am Coll Surg. 2009 Apr; 208(4):539-46.
-
Jain A, Sharma R, Ryan C, Safadjou S, Kashyap R, Mantry P, Maliakkal B, Orloff M. Response to antiviral therapy in liver transplant recipients with recurrent hepatitis C viral infection: a single center experience. Clin Transplant. 2010 Jan-Feb; 24(1):104-11.
-
Jain A, Patil VP, Horton P, Patel N, Kashyap R, Tsoulfas G, Orloff M, Bozorgzadeh A. Common iliac artery lying posterior to psoas major identified during kidney transplantation. Transplantation. 2008 Aug 27; 86(4):623-4.
-
Kashyap R, Bozorgzadeh A, Abt P, Tsoulfas G, Maloo M, Sharma R, Patel S, Dombroski D, Mantry P, Safadjou S, Jain A, Orloff M. Stratifying risk of biliary complications in adult living donor liver transplantation by magnetic resonance cholangiography. Transplantation. 2008 Jun 15; 85(11):1569-72.
-
Tretheway D, Jain A, LaPoint R, Sharma R, Orloff M, Milot P, Bozorgzadeh A, Ryan C. Should trichrome stain be used on all post-liver transplant biopsies with hepatitis C virus infection to estimate the fibrosis score? Liver Transpl. 2008 May; 14(5):695-700.
-
Jain A, Venkataramanan R, Sharma R, Kwong T, Abt P, Orloff M, Kashyap R, Tsoulfas G, Bozorgzadeh A. Pharmacokinetics of mycophenolic acid in live donor liver transplant patients vs deceased donor liver transplant patients. J Clin Pharmacol. 2008 May; 48(5):547-52.
-
Cassuto JR, Patel SA, Tsoulfas G, Orloff MS, Abt PL. The cumulative effects of cold ischemic time and older donor age on liver graft survival. J Surg Res. 2008 Jul; 148(1):38-44.
-
Jain A, Venkataramanan R, Sharma R, Kwong T, Orloff M, Abt P, Kashyap R, Tsoulfas G, Batzold P, Williamson M, Bozorgzadeh A. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients. Transplantation. 2008 Feb 27; 85(4):554-60.
-
Patel S, Cassuto J, Orloff M, Tsoulfas G, Zand M, Kashyap R, Jain A, Bozorgzadeh A, Abt P. Minimizing morbidity of organ donation: analysis of factors for perioperative complications after living-donor nephrectomy in the United States. Transplantation. 2008 Feb 27; 85(4):561-5.
-
Gordetsky J, Hislop S, Orloff M, Butler M, Erturk E. Subcapsular hepatic hematoma with right hepatic vein thrombosis: a complication of shock wave lithotripsy. Can Urol Assoc J. 2008 Feb; 2(1):61-3.
-
Jain A, Sharma R, Ryan C, Tsoulfas G, Orloff M, Abt P, Kashyap R, Batzold P, Sauberman L, Safadjou S, Graham M, Bozorgzadeh A. Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction. Liver Transpl. 2008 Feb; 14(2):202-9.
-
Tu Z, Bozorgzadeh A, Pierce RH, Kurtis J, Crispe IN, Orloff MS. TLR-dependent cross talk between human Kupffer cells and NK cells. J Exp Med. 2008 Jan 21; 205(1):233-44.
-
Nickels M, Jain A, Sharma R, Orloff M, Tsoulfas G, Kashyap R, Bozorgzadeh A. Polysubstance abuse in liver transplant patients and its impact on survival outcome. Exp Clin Transplant. 2007 Dec; 5(2):680-5.
-
Patel S, Orloff M, Tsoulfas G, Kashyap R, Jain A, Bozorgzadeh A, Abt P. Living-donor liver transplantation in the United States: identifying donors at risk for perioperative complications. Am J Transplant. 2007 Oct; 7(10):2344-9.
-
Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Liver Transpl. 2007 Jun; 13(6):807-13.
-
Jain A, Venkataramanan R, Kwong T, Mohanka R, Orloff M, Abt P, Kashyap R, Tsoulfas G, Mack C, Williamson M, Batzold P, Bozorgzadeh A. Pharmacokinetics of mycophenolic acid in liver transplant patients after intravenous and oral administration of mycophenolate mofetil. Liver Transpl. 2007 Jun; 13(6):791-6.
-
Tu Z, Bozorgzadeh A, Crispe IN, Orloff MS. The activation state of human intrahepatic lymphocytes. Clin Exp Immunol. 2007 Jul; 149(1):186-93.
-
Abt P, Kashyap R, Orloff M, Jain A, Tsoulfas G, Bozorgzadeh A, Olthoff K. Pediatric liver and kidney transplantation with allografts from DCD donors: A review of UNOS data. Transplantation. 2006 Dec 27; 82(12):1708-11.
-
Jain A, Orloff M, Abt P, Kashyap R, Mantry P, Bozorgzadeh A. Postoperative impact of intraoperative biochemical changes at the completion of parenchymal division in living-donor liver transplantation. Exp Clin Transplant. 2006 Dec; 4(2):544-8.
-
Jain A, Ryan C, Mohanka R, Orloff M, Abt P, Romano J, Bryan L, Batzold P, Mantry P, Bozorgzadeh A. Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies. Clin Transplant. 2006 Sep-Oct; 20(5):624-33.
-
Maloo M, Abt P, Kashyap R, Younan D, Zand M, Orloff M, Jain A, Pentland A, Scott G, Bozorgzadeh A. Nephrogenic systemic fibrosis among liver transplant recipients: a single institution experience and topic update. Am J Transplant. 2006 Sep; 6(9):2212-7.
-
Saad WE, Saad NE, Davies MG, Bozorgdadeh A, Orloff MS, Patel NC, Abt PL, Lee DE, Sahler LG, Kitanosono T, Sasson T, Waldman DL. Elective transjugular intrahepatic portosystemic shunt creation for portal decompression in the immediate pretransplantation period in adult living related liver transplant recipient candidates: preliminary results. J Vasc Interv Radiol. 2006 Jun; 17(6):995-1002.
-
Jain A, Mohanka R, Orloff M, Abt P, Ryan C, Bozorgzadeh A. Question of using valganciclovir for cytomegalovirus (CMV) infection prophylaxis in post-liver transplant recipients. Liver Transpl. 2006 Jun; 12(6):1020-1; author reply 1022-3.
-
Jain A, Mohanka R, Orloff M, Abt P, Kashyap R, Cullen J, Lansing K, Bozorgzadeh A. University of Wisconsin versus histidine-tryptophan-ketoglutarate for tissue preservation in live-donor liver transplantation. Exp Clin Transplant. 2006 Jun; 4(1):451-7.
-
Jain A, Menegus M, Mohanka R, Orloff M, Abt P, Mantry P, Bozorgzadeh A. HCV antibody quantitative levels in liver transplant patients: do they have any relevance in clinical practice? Exp Clin Transplant. 2006 Jun; 4(1):475-80.
-
Angona R, Abt P, Younan D, Massey T, Marvin M, Kashyap R, Richards D, Jones K, Queschenbach J, Zand M, Jain A, Orloff M, Bozorgzadeh A. Modification of a biventricular assist device to facilitate preservative infusion and organ recovery in a nonheart-beating donor. J Extra Corpor Technol. 2006 Jun; 38(2):157-60.
-
Jain A, Mohanka R, Orloff M, Abt P, Kashyap R, Kelley M, Burlee K, Bozorgzadeh A. Intravenous mycophenolate mofetil with low-dose oral tacrolimus and steroid induction for live donor liver transplantation. Exp Clin Transplant. 2005 Dec; 3(2):361-5.
-
Orloff MJ. Prophylactic portasystemic shunt in non-cirrhotic portal fibrosis: is it worthwhile? Nobody knows. Indian J Gastroenterol. 2005 Nov-Dec; 24(6):233-5.
-
Shah A, Kendall G, Demme RA, Taylor J, Bozorgzadeh A, Orloff M, Jain A, Abt P, Zand MS. Home glucometer monitoring markedly improves diagnosis of post renal transplant diabetes mellitus in renal transplant recipients. Transplantation. 2005 Sep 27; 80(6):775-81.
-
Kelley M, Jain A, Kashyap R, Orloff M, Abt P, Wrobble K, Venkataramanan R, Bozorgzadeh A. Change in oral absorption of tacrolimus in a liver transplant recipient after reversal of jejunoileal bypass: case report. Transplant Proc. 2005 Sep; 37(7):3165-7.
-
Jain A, Orloff M, Abt P, Kashyap R, Mohanka R, Lansing K, Kelley M, Bozorgzadeh A. Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine. Transplant Proc. 2005 Sep; 37(7):3187-9.
-
Jain A, Orloff M, Kashyap R, Lansing K, Betts R, Mohanka R, Menegus M, Ryan C, Bozorgzadeh A. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients? Transplant Proc. 2005 Sep; 37(7):3182-6.
-
Jain A, Orloff M, Abt P, Kashyap R, Mohanka R, Lansing K, Romano J, Bozorgzadeh A. Survival outcome after hepatic retransplantation for hepatitis C virus-positive and -negative recipients. Transplant Proc. 2005 Sep; 37(7):3159-61.
-
Jain A, Orloff M, Abt P, Kashyap R, Mohanka R, Lansing K, Bozorgzadeh A. Transplantation of liver grafts from older donors: impact on recipients with hepatitis C virus infection. Transplant Proc. 2005 Sep; 37(7):3162-4.
-
Shah A, Nadasdy T, Arend L, Brennan J, Leong N, Coppage M, Orloff M, Demme R, Zand MS. Treatment of C4d-positive acute humoral rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin. Transplantation. 2004 May 15; 77(9):1399-405.
-
Bozorgzadeh A, Jain A, Ryan C, Ornt D, Zand M, Mantry P, Lansing K, Orloff M. Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus. Transplantation. 2004 Apr 15; 77(7):1066-70.
-
Tan HP, Madeb R, Kovach SJ, Orloff M, Mieles L, Johnson LA, Bozorgzadeh A, Marcos A. Hypophosphatemia after 95 right-lobe living-donor hepatectomies for liver transplantation is not a significant source of morbidity. Transplantation. 2003 Oct 15; 76(7):1085-8.
-
Galaria II, Marcos A, Orloff M, Mieles L, Bozorgadeh A, Kovach S, Tan HP. Pulmonary actinomycosis in solid organ transplantation. Transplantation. 2003 Jun 15; 75(11):1914-5.
-
Marcos A, Killackey M, Orloff MS, Mieles L, Bozorgzadeh A, Tan HP. Hepatic arterial reconstruction in 95 adult right lobe living donor liver transplants: evolution of anastomotic technique. Liver Transpl. 2003 Jun; 9(6):570-4.
-
Mieles LA, Waldman D, Orloff MS. Arterioportal fistulae following segmental liver transplantation in a child. Pediatr Transplant. 2002 Oct; 6(5):419-22.
-
Illig KA, Orloff M, Lyden SP, Green RM. Transposed saphenous vein arteriovenous fistula revisited: new technology for an old idea. Cardiovasc Surg. 2002 Jun; 10(3):212-5.
-
Orloff MJ, Orloff MS, Girard B, Orloff SL. Bleeding esophagogastric varices from extrahepatic portal hypertension: 40 years' experience with portal-systemic shunt. J Am Coll Surg. 2002 Jun; 194(6):717-28; discussion 728-30.
-
Marcos A, Orloff M, Mieles L, Olzinski AT, Renz JF, Sitzmann JV. Functional venous anatomy for right-lobe grafting and techniques to optimize outflow. Liver Transpl. 2001 Oct; 7(10):845-52.
-
Marcos A, Orloff M, Mieles L, Olzinski A, Sitzmann J. Reconstruction of double hepatic arterial and portal venous branches for right-lobe living donor liver transplantation. Liver Transpl. 2001 Aug; 7(8):673-9.
-
Orloff MJ, Orloff MS, Girard B, Orloff SL. When is liver transplant indicated in cirrhosis with bleeding varices? Transplant Proc. 2001 Feb-Mar; 33(1-2):1366.
-
Orloff MJ, Daily PO, Orloff SL, Girard B, Orloff MS. Surgical treatment of Budd-Chiari syndrome--when is liver transplant indicated? Transplant Proc. 2001 Feb-Mar; 33(1-2):1435.
-
Orloff MJ, Daily PO, Orloff SL, Girard B, Orloff MS. A 27-year experience with surgical treatment of Budd-Chiari syndrome. Ann Surg. 2000 Sep; 232(3):340-52.
-
Orloff SL, Yin Q, Corless CL, Orloff MS, Rabkin JM, Wagner CR. Tolerance induced by bone marrow chimerism prevents transplant vascular sclerosis in a rat model of small bowel transplant chronic rejection. Transplantation. 2000 Apr 15; 69(7):1295-303.
-
Orloff LA, Orloff MS, Orloff SL, Orloff MJ. Lifelong prevention of mesangial enlargement by whole pancreas transplantation in rats with diabetes mellitus. Arch Surg. 1999 Aug; 134(8):889-97.
-
Gottlieb RH, Voci SL, Cholewinski SP, Hartley DF, Rubens DJ, Orloff MS, Bronsther OL. Sonography: a useful tool to detect the mechanical causes of renal transplant dysfunction. J Clin Ultrasound. 1999 Jul-Aug; 27(6):325-33.
-
Morrissey NJ, Blom D, Ryan CK, Fisher T, Bronsther O, Orloff MS. Tolerance induction permits the development of graft-versus-host disease: donor-mediated attack following small bowel transplantation in mixed chimeras. Transpl Immunol. 1999 Mar; 7(1):19-25.
-
Gottlieb RH, Voci SL, Cholewinski SP, Robinette WB, Rubens DJ, O'Mara RE, Orloff MS, Johansson M, Bronsther OL. Urine leaks in renal transplant patients. Diagnostic usefulness of sonography and renography. Clin Imaging. 1999 Jan-Feb; 23(1):35-9.
-
Erturk E, Burzon DT, Orloff M, Rabinowitz R. Outcome of patients with vesicoureteral reflux after renal transplantation: the effect of pretransplantation surgery on posttransplant urinary tract infections. Urology. 1998 May; 51(5A Suppl):27-30.
-
Blom D, Morrissey N, Mesonero C, Zuo XJ, Jordan S, Fisher T, Bronsther O, Orloff MS. Tolerance induction by intrathymic inoculation prevents chronic renal allograft rejection. Transplantation. 1998 Jan 27; 65(2):272-5.
-
Blom D, Orloff MS. A more versatile and reliable method for renal transplantation in the rat. Microsurgery. 1998; 18(4):267-9.
-
Waldman DL, Lee DE, Bronsther O, Orloff MS. Use of intraoperative ultrasonography during hepatic transplantation. J Ultrasound Med. 1998 Jan; 17(1):1-6; quiz 7-8.
-
Orloff MJ, Orloff MS, Orloff SL, Girard B. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites. J Am Coll Surg. 1997 Jun; 184(6):557-70.
-
Morrissey NJ, Blom D, Ryan C, Fisher T, Bronsther O, Orloff M. Graft versus host disease in rats made tolerant for organ allografts. J Surg Res. 1997 May; 69(2):307-15.
-
Orloff MJ, Orloff MS, Orloff SL, Girard B. Portal vein thrombosis in cirrhosis with variceal hemorrhage. J Gastrointest Surg. 1997 Mar-Apr; 1(2):123-30, discussion 130-1.
-
Blom D, Morrissey NJ, Mesonero C, Coppage M, Fisher T, Zuo XJ, Jordan SC, Orloff MS. Induction of specific tolerance through mixed hematopoietic chimerism prevents chronic renal allograft rejection in a rat model. Surgery. 1996 Aug; 120(2):213-9; discussion 219-20.
-
McKenna BA, Pabico RC, Bronsther OL, Morris MC, Orloff MS, Erturk E. Tacrolimus (FK 506): a whole blood assay as measured on the Abbott IMx analyzer. Transplant Proc. 1996 Apr; 28(2):988-90.
-
Orloff MS, DeMara EM, Coppage ML, Leong N, Zuo XJ, Prehn J, Jordan SC. Alterations of the interleukin-4 pathway in production of tolerance by mixed hematopoietic chimerism. Surgery. 1995 Aug; 118(2):212-9.
-
Orloff MJ, Orloff MS, Orloff SL, Haynes KS. Treatment of bleeding from portal hypertensive gastropathy by portacaval shunt. Hepatology. 1995 Apr; 21(4):1011-7.
-
Orloff MJ, Bell RH, Orloff MS, Greenburg AG, Hardison WG. Emergency portacaval shunt: a perspective on the perspective. Hepatology. 1995 Apr; 21(4):1203-6.
-
Orloff MJ, Orloff MS, Orloff SL, Rambotti M, Girard B. Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver. J Am Coll Surg. 1995 Mar; 180(3):257-72.
-
Orloff MS, DeMara EM, Coppage ML, Leong N, Fallon MA, Sickel J, Zuo XJ, Prehn J, Jordan SC. Prevention of chronic rejection and graft arteriosclerosis by tolerance induction. Transplantation. 1995 Jan 27; 59(2):282-8.
-
Orloff MJ, Bell RH, Orloff MS, Hardison WG, Greenburg AG. Prospective randomized trial of emergency portacaval shunt and emergency medical therapy in unselected cirrhotic patients with bleeding varices. Hepatology. 1994 Oct; 20(4 Pt 1):863-72.
-
Orloff MS, Reed AI, Erturk E, Kruk RA, Paprocki SA, Cimbalo SC, Cerilli GJ. Nonheartbeating cadaveric organ donation. Ann Surg. 1994 Oct; 220(4):578-83; discussion 583-5.
-
Orloff MJ, Daily PO, Orloff LA, Orloff MS. Free jejunal autograft combined with extensive esophagogastrectomy for unshuntable extrahepatic portal hypertension. J Thorac Cardiovasc Surg. 1994 Aug; 108(2):346-53.
-
Orloff MS, Fallon MA, DeMara E, Coppage ML, Leong N, Cerilli J. Induction of specific tolerance to small-bowel allografts. Surgery. 1994 Aug; 116(2):222-8.
-
Orloff MS, Orloff SL, DeMara EM, Coppage ML, Leong N, Fallon MA. Induction of tolerance to small bowel allotransplants by mixed allogeneic chimerism. Transplant Proc. 1994 Jun; 26(3):1585-6.
-
Orloff MJ, Orloff MS, Rambotti M. Treatment of bleeding esophagogastric varices due to extrahepatic portal hypertension: results of portal-systemic shunts during 35 years. J Pediatr Surg. 1994 Feb; 29(2):142-51; discussion 151-4.
-
Orloff MJ, Orloff MS, Daily PO, Girard B. Long-term results of radical esophagogastrectomy for bleeding varices due to unshuntable extrahepatic portal hypertension. Am J Surg. 1994 Jan; 167(1):96-102; discussion 102-3.
-
Orloff MJ, Orloff MS, Daily PO. Long-term results of treatment of Budd-Chiari syndrome with portal decompression. Arch Surg. 1992 Oct; 127(10):1182-7; discussion 1187-8.
-
Orloff MJ, Orloff MS, Rambotti M, Girard B. Is portal-systemic shunt worthwhile in Child's class C cirrhosis? Long-term results of emergency shunt in 94 patients with bleeding varices. Ann Surg. 1992 Sep; 216(3):256-66; discussion 266-8.
-
Baquerizo A, Kamada N, Hart J, Millis JM, Pera C, Olthoff K, Imagawa D, Orloff M, Busuttil RW. Influence of number and timing of serum transfusions on liver allograft survival in rats. Transplant Proc. 1990 Aug; 22(4):2020-2.
-
Pace RF, Blenkharn JI, Edwards WJ, Orloff M, Blumgart LH, Benjamin IS. Intra-abdominal sepsis after hepatic resection. Ann Surg. 1989 Mar; 209(3):302-6.
-
Orloff MJ, Girard B. Long term results of treatment of Budd-Chiari syndrome by side to side portacaval shunt. Surg Gynecol Obstet. 1989 Jan; 168(1):33-41.
-
Orloff MS, Blumgart LH. Surgical approaches to benign and malignant biliary strictures. Semin Liver Dis. 1987 Nov; 7(4):343-55.
-
Bunnett NW, Orloff MS, Goto Y, Corbet HJ, Garcia R, Reeve JR, Debas HT, Walsh JH. Partial purification of a novel stimulant of gastric acid secretion from canine non-antral mucosa. Life Sci. 1986 Mar 10; 38(10):887-94.
-
Orloff MS, Turner AJ, Bunnett NW. Catabolism of substance P and neurotensin in the rat stomach wall is susceptible to inhibitors of angiotensin converting enzyme. Regul Pept. 1986 Mar; 14(1):21-31.
-
Bunnett NW, Orloff MS, Turner AJ. Catabolism of substance P in the stomach wall of the rat. Life Sci. 1985 Aug 19; 37(7):599-606.
-
Bunnett NW, Clark B, Debas HT, Del Milton RC, Kovacs TO, Orloff MS, Pappas TN, Reeve JR, Rivier JE, Walsh JH. Canine bombesin-like gastrin releasing peptides stimulate gastrin release and acid secretion in the dog. J Physiol. 1985 Aug; 365:121-30.
-
Orloff LA, Orloff MS, Bunnett NW, Walsh JH. Dopamine and norepinephrine in the alimentary tract changes after chemical sympathectomy and surgical vagotomy. Life Sci. 1985 Apr 29; 36(17):1625-31.
-
Bunnett NW, Kobayashi R, Orloff MS, Reeve JR, Turner AJ, Walsh JH. Catabolism of gastrin releasing peptide and substance P by gastric membrane-bound peptidases. Peptides. 1985 Mar-Apr; 6(2):277-83.
-
Orloff MS, Reeve JR, Ben-Avram CM, Shively JE, Walsh JH. Isolation and sequence analysis of human bombesin-like peptides. Peptides. 1984 Sep-Oct; 5(5):865-70.
-
Bunnett NW, Mogard M, Orloff MS, Corbet HJ, Reeve JR, Walsh JH. Catabolism of neurotensin in interstitial fluid of the rat stomach. Am J Physiol. 1984 Jun; 246(6 Pt 1):G675-82.
|
Orloff's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
